POSC141 Evaluation of the Long-Term Cost-Effectiveness of Ideglira Versus Liraglutide for Patients with Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs in China
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.545
https://www.valueinhealthjournal.com/article/S1098-3015(21)02340-8/fulltext
Title :
POSC141 Evaluation of the Long-Term Cost-Effectiveness of Ideglira Versus Liraglutide for Patients with Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02340-8&doi=10.1016/j.jval.2021.11.545
First page :
Section Title :
Open access? :
No
Section Order :
10083